A semi-automated vibriocidal assay for improved measurement of cholera vaccine-induced immune responses

Journal of Microbiological Methods

Volumn 71, Issue 2, 2007, Pages 141-146

  Yang, Jae Seung ^a,b   Kim, Hye Jin ^a,d   Yun, Cheol Heui ^c   Kang, Seok Seong ^d   Im, Jintaek ^d   Kim, Hak Sung ^b   Han, Seung Hyun ^a,d  

^a International Vaccine Institute   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Cholera vaccine; Improved vibriocidal assay; Vibrio cholerae

Indexed keywords

AGAR; CHOLERA VACCINE; PLACEBO;

ACCURACY; ANTIBODY TITER; ARTICLE; AUTOANALYSIS; BACTERICIDAL ACTIVITY; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG EFFICACY; ESCHERICHIA COLI; EVALUATION; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MICROTITER PLATE ASSAY; PRIORITY JOURNAL; SALMONELLA TYPHI; SEMI AUTOMATED ASSAY; TREATMENT RESPONSE; VIBRIO CHOLERAE;

ANTIBODIES, BACTERIAL; CHOLERA; CHOLERA VACCINES; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; HUMANS; IMMUNOASSAY; MICROBIAL VIABILITY; SALMONELLA TYPHI; SENSITIVITY AND SPECIFICITY; SERUM; VIBRIO CHOLERAE;

ESCHERICHIA COLI; SALMONELLA TYPHI; VIBRIO CHOLERAE;

EID: 35048857794     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2007.08.009     Document Type: Article

References (19)

1. Anh D.D., Canh do G., Lopez A.L., Thiem V.D., Long P.T., Son N.H., Deen J., von Seidlein L., Carbis R., Han S.H., Shin S.H., Attridge S., Holmgren J., and Clemens J. Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine 25 (2007) 1149-1155
2. Attridge S.R., Johansson C., Trach D.D., Qadri F., and Svennerholm A.M. Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139. Clin. Diagn. Lab. Immunol. 9 (2002) 383-387
3. Benenson A.S., Saad A., and Mosley W.H. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique. Bull World Health Organ. 38 (1968) 277-285
4. Burton R.L., and Nahm M.H. Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies. Clin. Vaccine Immunol. 13 (2006) 1004-1009
5. Chatterjee S.N., and Chaudhuri K. Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization. Biochim. Biophys. Acta 1639 (2003) 65-79
6. Feeley J.C. Immune response to Vibrio cholerae. In: Rose N.R., and Friedman H. (Eds). Mannual of clinical immunology (1976), American Society for Microbiology, Washington 289-295
7. Finkelstein R.A. Vibriocidal antibody inhibition (VAI) analysis: a technique for the identification of the predominant vibriocidal antibodies in serum and for the detection and identification of Vibrio cholerae antigens. J. Immunology 89 (1962) 264-271
8. Holmgren J., Clemens J., Sack D.A., and Svennerholm A.M. New cholera vaccines. Vaccine 7 (1989) 94-96
9. Holmgren J., Svennerholm A.M., and Ouchterlony O. Quantitation of vibriocidal antibodies using agar plague techniques. Acta Pathol. Microbiol. Scand., Sect. B. Microbiol. Immunol. 79 (1971) 708-714
10. Kim K.H., Yu J., and Nahm M.H. Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies. Clin. Diagn. Lab. Immunol. 10 (2003) 616-621
11. Levine M.M.P.N. Immunity and vaccine development. In: Barua D.G.W. (Ed). cholera (1992) 285-327 New York
12. Mosley W.H., Aziz K.M., Mizanur Rahman A.S., Alauddin Chowdhury A.K., Ahmed A., and Fahimuddin M. Report of the 1966-67 cholera vaccine trial in rural East Pakistan. Bull. World Health Organ. 47 (1972) 229-238
13. Otten M.A., and van Egmond M. The Fc receptor for IgA (FcalphaRI, CD89). Immunol. Lett. 92 (2004) 23-31
14. Putman M., Burton R., and Nahm M.H. Simplified method to automatically count bacterial colony forming unit. J. Immunol. Methods 302 (2005) 99-102
15. Quick R.E., Venczel L.V., Gonzalez O., Mintz E.D., Highsmith A.K., Espada A., Damiani E., Bean N.H., De Hannover E.H., and Tauxe R.V. Narrow-mouthed water storage vessels and in situ chlorination in a Bolivian community: a simple method to improve drinking water quality. Am. J. Trop. Med. Hyg. 54 (1996) 511-516
16. Svennerholm A.M., Jertborn M., Gothefors L., Karim A.M., Sack D.A., and Holmgren J. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149 (1984) 884-893
17. Tacket C.O., Cohen M.B., Wasserman S.S., Losonsky G., Livio S., Kotloff K., Edelman R., Kaper J.B., Cryz S.J., Giannella R.A., Schiff G., and Levine M.M. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination. Infect. Immun. 67 (1999) 6341-6345
18. Thom S.M., Horobin R.W., Seidler E., and Barer M.R. Factors affecting the selection and use of tetrazolium salts as cytochemical indicators of microbial viability and activity. J. Appl. Bacteriol. 74 (1993) 433-443
19. Vu D.T., Hossain M.M., Nguyen D.S., Nguyen T.H., Rao M.R., Do G.C., Naficy A., Nguyen T.K., Acosta C.J., Deen J.L., Clemens J.D., and Dang D.T. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam. J. Health Popul. Nutr. 21 (2003) 304-308